Guangzhou Wondfo Biotech Co.,Ltd (300482.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap9.57B
Enterprise Value9.12B
P/E Ratio-49.83
PEG Ratio0.53
Price/Sales Ratio4.37
Price/Book Ratio1.48
Enterprise/Revenue4.53
Enterprise/EBITDA-455.83

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.09
Operating Margin-0.13
AD

Management Effectiveness

Return On Assets-0.02
Return On Equity-0.03

Income Statement

Revenue2.09B
Revenue/Share4
Gross Profit1.19B
EBITDA179.91M
Net Income-63.02M
Diluted EPS-0.13

Balance Sheet

Total Cash1.97B
Total Cash/Share4.22
Total Debt669.62M
Total Debt/Equity0.12
Current Ratio3.22
Book Value Per Share11.95

Price History

52-Week Change-28.35
52-Week High26.29
52-Week Low15.47
Moving Average 50 Days17.66
Moving Average 200 Days19.45

Statistics

Average Volume11.81M
Shares Outstanding468.09M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.22
Trailing Annual Dividend Yield1.26
Payout Ratio-1.11
Last Split Factor13:10
Last Split DateMay 26, 2021
AD